BioLife Solutions Inc
NASDAQ:BLFS
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
BioLife Solutions Inc
NASDAQ:BLFS
|
801.5m USD | -62.9 | ||
JP |
Hoya Corp
TSE:7741
|
6.3T JPY | 28.7 | ||
CH |
Alcon AG
SIX:ALC
|
36B CHF | 31.3 | ||
DK |
Coloplast A/S
CSE:COLO B
|
190B DKK | 37.2 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
21B USD | 25.6 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 38.2 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.7T KRW | -122.2 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
60.4B CNY | 40.2 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 343.3 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 17.2 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.3B USD | 119.4 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.